Target intelligence / Profile preview

TLE family member 3, transcriptional corepressor (TLE3)

Target
TLE3
Molecular classification
Transcription corepressor, Transcriptional regulator, Other
01

Overview

TLE family member 3, transcriptional corepressor (TLE3), is a member of the Groucho/transducin-like enhancer (Gro/TLE) family of transcriptional corepressors that does not itself bind DNA but modulates gene expression by interacting with a variety of transcription factors[1][6][7]. TLE3 participates in several developmental and metabolic signaling pathways including Wnt, Notch, and PPARγ, acting as a key regulator of adipogenesis and memory B cell differentiation[2][4][5]. In adipogenesis, TLE3 integrates PPARγ and Wnt signaling, enhancing PPARγ-mediated gene activation while suppressing anti-adipogenic Wnt signals, which can influence systemic insulin sensitivity[2]. TLE3 also interacts with transcription factors such as Hhex to promote memory B cell development[4]. In cancer, particularly lung cancer, higher TLE3 expression has been linked to improved patient outcomes[1]. There are currently no approved drugs that directly target TLE3, and its manipulation for therapeutic purposes poses potential challenges due to its broad effects on transcriptional regulation.

Other names
Transducin-like enhancer protein 3KIAA1547ESG3ESGGRG3Enhancer of split groucho-like protein 3HsT18976enhancer of split groucho 3transducin-like enhancer of split 3enhancer of split groucho-like protein 3E(sp1) homolog (Drosophila)homolog of Drosophila E(sp1)
02

Mechanism of action

Not applicable (not a drug target; no small molecule or biologic modulators described)

03

Biological functions

Transcriptional repressionRegulation of adipogenesisNegative regulation of Wnt signaling pathwayRegulation of Notch signalingRegulation of cell fate during developmentPromotion of memory B cell differentiation
04

Disease associations

Cancer (e.g., higher TLE3 expression correlates with higher survival in lung cancer)Metabolic diseases (involvement in adipogenesis and insulin resistance)Immune dysfunction (role in B cell and memory B cell differentiation)
05

Safety considerations

None specifically known; as a transcriptional corepressor, modulation may affect broad gene expression with unpredictable systemic effects
06

Biomarkers

Potential prognostic marker in lung cancer (higher TLE3 expression linked to better outcomes)

Beyond the preview

Go deeper on TLE family member 3, transcriptional corepressor (TLE3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLE family member 3, transcriptional corepressor (TLE3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call